Literature DB >> 29808447

Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?

Mariana Ciocchini1, Carlos G Musso2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29808447     DOI： 10.1007/s11255-018-1896-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  11 in total

1.  C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

Authors:  Andrew S Bomback; Dominick Santoriello; Rupali S Avasare; Renu Regunathan-Shenk; Pietro A Canetta; Wooin Ahn; Jai Radhakrishnan; Maddalena Marasa; Paul E Rosenstiel; Leal C Herlitz; Glen S Markowitz; Vivette D D'Agati; Gerald B Appel
Journal:  Kidney Int       Date:  2018-01-06       Impact factor: 10.612

Review 2.  Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.

Authors:  Mariana Ciocchini; Jorge Arbelbide; Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2017-04-19       Impact factor: 2.370

3.  Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.

Authors:  Sophie Chauvet; Véronique Frémeaux-Bacchi; Florent Petitprez; Alexandre Karras; Laurent Daniel; Stéphane Burtey; Gabriel Choukroun; Yahsou Delmas; Dominique Guerrot; Arnaud François; Moglie Le Quintrec; Vincent Javaugue; David Ribes; Laurence Vrigneaud; Bertrand Arnulf; Jean Michel Goujon; Pierre Ronco; Guy Touchard; Frank Bridoux
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

4.  What is the place of POEMS syndrome in the current classification of monoclonal gammopathies of renal significance?

Authors:  Mariana Ciocchini; Carlos Guido Musso
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

5.  C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Authors:  Ladan Zand; Andrea Kattah; Fernando C Fervenza; Richard J H Smith; Samih H Nasr; Yuzhou Zhang; Julie A Vrana; Nelson Leung; Lynn D Cornell; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2013-04-26       Impact factor: 8.860

6.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

7.  Thrombotic microangiopathy associated with monoclonal gammopathy.

Authors:  Aishwarya Ravindran; Ronald S Go; Fernando C Fervenza; Sanjeev Sethi
Journal:  Kidney Int       Date:  2016-12-18       Impact factor: 10.612

8.  [Renal manifestation in POEMS syndrome].

Authors:  M Soubrier; P Deteix; G Derray; J J Dubost; B Sauvezie; A Chapman; J L Bussière
Journal:  Nephrologie       Date:  1994

9.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Timothy H J Goodship; H Terence Cook; Fadi Fakhouri; Fernando C Fervenza; Véronique Frémeaux-Bacchi; David Kavanagh; Carla M Nester; Marina Noris; Matthew C Pickering; Santiago Rodríguez de Córdoba; Lubka T Roumenina; Sanjeev Sethi; Richard J H Smith
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612

10.  C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome.

Authors:  Isaac E Lloyd; Alexander Gallan; Hunter K Huston; Kalani L Raphael; Dylan V Miller; Monica P Revelo; Mazdak A Khalighi
Journal:  Clin Kidney J       Date:  2016-09-23
View more
  2 in total

Review 1.  Pathophysiology and management of monoclonal gammopathy of renal significance.

Authors:  Ankur Jain; Richard Haynes; Jaimal Kothari; Akhil Khera; Maria Soares; Karthik Ramasamy
Journal:  Blood Adv       Date:  2019-08-13

2.  Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.

Authors:  Guangyan Nie; Lianqin Sun; Chengning Zhang; Yanggang Yuan; Huijuan Mao; Zhen Wang; Jianyong Li; Suyan Duan; Changying Xing; Bo Zhang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.